Calcified Tissue International

, Volume 49, Issue 3, pp 155–160 | Cite as

Diabetic bone disease

  • Roger Bouillon


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Morrison LB, Bogan IK (1927) Bone development in diabetic children: a roentgen study. Am J Med Sci 174:313–319Google Scholar
  2. 2.
    Albright F, Reifenstein EC (1948) The parathyroid glands and metabolic bone disease: selected studies. Williams & Wilkins, BaltimoreGoogle Scholar
  3. 3.
    Berney PW (1952) Osteoporosis and diabetes mellitus. J Iowa Med Soc 42:10–12PubMedGoogle Scholar
  4. 4.
    Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241–245PubMedCrossRefGoogle Scholar
  5. 5.
    Ringe JD, Kuhlencordt F, Kuhnau J (1976) Mineralgehalt des skeletss bei Langzeitdiabetikern. Densitometrischer Beitrag zue “Osteopathia diabetica.” Dtsch Med Wochenschr 101:280PubMedCrossRefGoogle Scholar
  6. 6.
    Rosenbloom AL, Lezotte DC, Weber FT, Gudat J, Heller DR, Weber ML, Klein S, Kennedy BB (1977) Diminution of bone mass in childhood diabetes. Diabetes 26:1052–1055PubMedGoogle Scholar
  7. 7.
    Santiago JV, McAlister WH, Ratzan SK, Bussman Y, Haymond MW, Shakelford G, Weldon VV (1977) Decreased cortical thickness and osteopenia in children with diabetes mellitus. J Clin Endocrinol Metab 45:845–848PubMedGoogle Scholar
  8. 8.
    McNair P, Madsbad S, Christiansen C, Christensen MS, Faber OK, Binder C, Transbøl I (1979) Bone loss in diabetes: effects of metabolic state. Diabetologia 17:283–286PubMedCrossRefGoogle Scholar
  9. 9.
    McNair P, Christiansen C, Christensen MS, Madsbad S, Faber OK, Binder C, Transbøl I (1981) Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patients. Eur J Clin Invest 11:55–59PubMedGoogle Scholar
  10. 10.
    Frazer TE, White NH, Hough S, Santiago JV, McGee BR, Bryce G, Mallon J, Avioli LV (1981) Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab 53:1154–1159PubMedGoogle Scholar
  11. 11.
    Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1981) Osteopenia in juvenile diabetes. Calcif Tissue Int 33:455–457PubMedCrossRefGoogle Scholar
  12. 12.
    Wiske PS, Wentworth SM, Norton JA, Epstein S, Johnston CC (1982) Evaluation of bone mass and growth in young diabetics. Metabolism 31:848–854PubMedCrossRefGoogle Scholar
  13. 13.
    Hui SL, Epstein S, Johnston CC (1985) A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 60:74–80PubMedGoogle Scholar
  14. 14.
    Hough FS (1987) Alterations of bone and mineral metabolism in diabetes mellitus. II. Clinical studies in 206 patients with type I diabetes mellitus. South African Med J 72:120–126Google Scholar
  15. 15.
    Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J (1988) Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37:8–12PubMedGoogle Scholar
  16. 16.
    Giacca A, Fassina A, Caviezel F, Cattaneo AG, Caldirola G, Pozza G (1988) Bone mineral density in diabetes mellitus. Bone 9:29–36PubMedCrossRefGoogle Scholar
  17. 17.
    Leon M, Larrodera L, Lledo G, Hawkins F (1989) Study of bone loss in diabetes mellitus type I. Diabetes Res Clin Pract 6:237–242PubMedCrossRefGoogle Scholar
  18. 18.
    Meema HE, Meema S (1967) The relationship of diabetes mellitus and body weight to osteoporosis in elderly females. Can Med Assoc J 96:132–139PubMedGoogle Scholar
  19. 19.
    De Leeuw I, Abs R (1977) Bone mass and bone density in maturity-type diabetics measured by the125I photon-absorption technique. Diabetes 26:1130–1135PubMedGoogle Scholar
  20. 20.
    Ishida H, Seino Y, Matsukura S, Ikeda M, Yawata M, Yamashita G, Ishizuka S, Imura H (1985) Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (non-insulin-dependent) diabetes. Metabolism 34:797–801PubMedCrossRefGoogle Scholar
  21. 21.
    Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM (1987) Osteoporosis in type II diabetes. Acta Diabetologia 24:305–310Google Scholar
  22. 22.
    Johnston CC, Hui SL, Longcope C (1985) Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics. Metabolism 34:544–550PubMedCrossRefGoogle Scholar
  23. 23.
    Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KB, Melton LJ (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with age. J Clin Invest 67:328–335PubMedCrossRefGoogle Scholar
  24. 24.
    Meema S, Reid DB, Meema HE (1973) Age trends of bone mineral mass, muscle width and subcutaneous fat in normals and osteoporosis. Calcif Tissue Res 12:101–112PubMedCrossRefGoogle Scholar
  25. 25.
    Lips PTAM (1982) Metabolic causes and prevention of femoral neck fractures. Thesis, Vrije Universiteit Amsterdam, Rodopi, Amsterdam, pp 1–162Google Scholar
  26. 26.
    Yue DK, McLennan S, Handelsman DJ, Delbridge L, Reeve T, Turtle JR (1985) The effects of cyclooxygenase, and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats. Diabetes 34:74–78PubMedGoogle Scholar
  27. 27.
    Alffram PA (1964) An epidemiologic study of cervical and trochanteric fractures of the femur in an urban population. Acta Orthop Scand 65 (suppl):6–109Google Scholar
  28. 28.
    Menczel J, Makin M, Robin G, Jaye I, Naor E (1972) Prevalence of diabetes mellitus in Jerusalem. Israel J Med Sci 8:918–919PubMedGoogle Scholar
  29. 29.
    Hutchinson TA, Polansky SM, Feinstein AR (1979) Postmenopausal oestrogens protect against fractures of hip and distal radius. Lancet ii:705–709CrossRefGoogle Scholar
  30. 30.
    Gallagher JC, Riggs BL, DeLuca HF (1980) Effect of estrogen on calcium absorption and serum vitamin D metabolites in post-menopausal osteoporosis. J Clin Endocrinol Metab 51:1359–1364PubMedGoogle Scholar
  31. 31.
    Wientroub S, Eisenberg D, Tardiman R, Weissman SI, Salama R (1980) Is diabetic osteoporosis due to microangiopathy? Lancet ii:983CrossRefGoogle Scholar
  32. 32.
    Heath H, Melton LJ, Chu CP (1980) Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567–570PubMedCrossRefGoogle Scholar
  33. 33.
    Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM (1981) Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:28–31PubMedGoogle Scholar
  34. 34.
    Raskin P, Stevenson MRM, Barilla DE, Pak CYC (1978) The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol 9:329–335Google Scholar
  35. 35.
    Bouillon R, Nyomba BL, Verhaeghe J, Visser WJ, Thomasset M (1987) Le métabolisme phosphocalcique, dans le diabète sucré de l'homme et du rat BB. In: Journées annuelles de Diabétologie de l'Hôtel-Dieu (M. Rathery), Médecine Sciences, Flammarion, Paris, pp 103–115Google Scholar
  36. 36.
    Schneider LE, Schedl HP (1972) Diabetes and intestinal calcium absorption in the rat. Am J Physiol 223:1319–1323PubMedGoogle Scholar
  37. 37.
    Spencer EM, Khalil M, Tobiassen O (1980) Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1α-hydroxylase, activity. Endocrinology 107:300–305PubMedGoogle Scholar
  38. 38.
    Shires R, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1980) Effects of semistarvation on skeletal homeostasis. Endocrinology 107:1530–1535PubMedGoogle Scholar
  39. 39.
    Wood RJ, Allen LH, Bronner F (1984) Regulation of calcium metabolism in streptozotocin-induced diabetes. Am J Physiol 247:R120-R123PubMedGoogle Scholar
  40. 40.
    Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R (1989) Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 124:565–572PubMedGoogle Scholar
  41. 41.
    Verhaeghe J, Bouillon R, Lissens W, Visser WJ, Van Assche FA (1988) Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism. Am J Physiol 254:E496-E504PubMedGoogle Scholar
  42. 42.
    Williams G, Bloom SR (1989) Regulatory peptides, the hypothalamus and diabetes. Diabetic Med 6:472–485PubMedGoogle Scholar
  43. 43.
    Schneider LE, Schedl HP, McCain T, Haussler MR (1977) Experimental diabetes reduces circulating 1,25-dihydroxy-vitamin D in the rat. Science 196:1452–1454PubMedCrossRefGoogle Scholar
  44. 44.
    Nyomba BL, Bouillon R, Lissens W, Van Baelen H, De Moor P (1985) 1,25-Dihydroxy vitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116:2483–2488PubMedGoogle Scholar
  45. 45.
    Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV (1981) The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 97:231–240PubMedGoogle Scholar
  46. 46.
    Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1981) Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 108:2228–2234PubMedGoogle Scholar
  47. 47.
    Nyomba BL, Bouillon R, Bidingija M, Kandjingu K, De Moor P (1986) Vitamin D metabolites and their binding protein in adult diabetic patients. Diabetes 35:911–915PubMedGoogle Scholar
  48. 48.
    Henry HL (1981) Insulin permits parathyroid hormone stimulation of 1,25-dihydroxyvitamin D3 production in cultured kidney cells. Endocrinology 108:733–735PubMedGoogle Scholar
  49. 49.
    Kurose H, Sonn YM, Jafari A, Birge SJ, Avioli LV (1985) Effects of prostaglandin E2 and indomethacin on 25-hydroxyvitamin D3-1-alpha-hydroxylase activity in isolated kidney cells of normal and streptozotocin-induced diabetic rats. Calcif Tissue Int 37:625–629PubMedGoogle Scholar
  50. 50.
    Verhaeghe J, Van Herck E, Visser WJ, Suiker AMH, Thomasset M, Einhorn TA, Faierman E, Bouillon R (1990) Bone and mineral metabolism in BB rats with long-term diabetes: decreased bone turnover and osteoporosis. Diabetes 39:477–482PubMedGoogle Scholar
  51. 51.
    Ishida H, Cunningham NS, Henry HL, Norman AW, (1988) The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice. Endocrinology 122:2436–2443PubMedGoogle Scholar
  52. 52.
    Schedl HP, Heath H, Wenger J (1978) Serum calcitonin and parathyroid hormone in experimental diabetes: effects of insulin treatment. Endocrinology 103:1368–1373PubMedGoogle Scholar
  53. 53.
    Landeros O, Frost HM (1964) Radial rate of osteon closure, measured by means of tetracycline labelling. Henry Ford Hosp Med Bull 12:499–505Google Scholar
  54. 54.
    Wu K, Schubeck KE, Frost HM, Villanueava A (1970) Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis. Calcif Tissue Res 6:204–219PubMedCrossRefGoogle Scholar
  55. 55.
    Aubia J, Serrano S, Marinoso L, Hojman L, Diez A, Lloveras J, Masramon J (1988) Osteodystrophy of diabetics in chronic dialysis: a histomorphometric study. Calcif Tissue Int 42:297–301PubMedGoogle Scholar
  56. 56.
    Andress DL, Hercz G, Kopp JB, Endres DB, Norris KC, Coburn JW, Sherrard DJ (1987) Bone histomorphometry of renal osteo-dystrophy in diabetic patients. J Bone Min Res 2:525–531CrossRefGoogle Scholar
  57. 57.
    Goodman WG, Hori MT (1984) Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825–831PubMedGoogle Scholar
  58. 58.
    Verhaeghe J, Suiker AMH, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J, Bouillon R (1989) Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124:573–582PubMedGoogle Scholar
  59. 59.
    Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti, S (1988) Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. Endocrinology 123:290–295PubMedGoogle Scholar
  60. 60.
    Ishida H, Seino Y, Taminato T, Usami M, Takeshita N, Seino Y, Tsutsumi C, Moriuchi S, Akiyama Y, Hara K, Imura H (1988) Circulating levels and bone contents of bone gammacarboxyglutamic acid-containing protein are decreased in streptozotocin-induced diabetes. Diabetes 37:702–706PubMedGoogle Scholar
  61. 61.
    Rico H, Hernandez ER, Cabranes JA, Gomez-Castresana F (1989) Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics. Calcif Tissue Int 45:71–73PubMedCrossRefGoogle Scholar
  62. 62.
    Bouillon R, Verhaeghe J, Visser WJ, Suiker AMH (1989) Bone and mineral metabolism in the long-term diabetic BB rat (abstract 1627) The Endocrine Society, 71st Annual Meeting 1989, Seattle, WashingtonGoogle Scholar
  63. 63.
    Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254–260PubMedCrossRefGoogle Scholar
  64. 64.
    Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828PubMedCrossRefGoogle Scholar
  65. 65.
    Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER (1986) Growth restoration of insulin-deficient rats by recombinant human insulin-like growth factor I. Nature 323:169–171PubMedCrossRefGoogle Scholar
  66. 66.
    Nyomba BL, Bouillon R, De Moor P (1987) Evidence for an interaction of insulin and sex steroids in the regulation of vitamin D metabolism in the rat. J Endocrinol 115:295–301PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1991

Authors and Affiliations

  • Roger Bouillon
    • 1
  1. 1.Laboratory for Experimental Medicine and EndocrinologyCatholic University Onderwijs en Navorsing, GasthuisbergLeuvenBelgium

Personalised recommendations